Psychiatry and Neurology, Neurology · Orange, CA
NPI
1871679373
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
101 the City Dr S
Orange, CA, 92868
Phone (714) 456-7707
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
684 services
Medicare patients, 2024
307
Average age 75
Drug cost, 2024
$332K
2,519 prescriptions
Company payments, 2025
$729
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vivek Jain was code 99213 (office e&m - established), 362 times for 209 patients. In total Vivek Jain billed 684 services in 16 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 362 | 209 | $82.55 | $30K |
| 99441 Telephone Services | Office | 142 | 100 | $52.82 | $7,501 |
| 99214 Office E&M - Established | Office | 108 | 107 | $118.99 | $13K |
| 95909 Electrical Nerve Conductivity | Office | 12 | 12 | $135.65 | $1,628 |
| 99442 Telephone Services | Office | 11 | 11 | $88.44 | $973 |
By year: 2022 $54K for 685 services; 2023 $52K for 632 services; 2024 $57K for 684 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vivek Jain prescribed most often to Medicare patients was Memantine Hcl, with 282 prescriptions and refills. In total Vivek Jain wrote 2,519 Medicare prescriptions that cost $332K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 282 | 391 | 48 | $8,220 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 228 | 337 | 38 | $4,736 |
| Gabapentin Generic | 202 | 241 | 40 | $2,905 |
| Donepezil Hcl Generic | 190 | 400 | 53 | $1,702 |
| Levetiracetam Generic | 139 | 201 | 27 | $4,324 |
| Escitalopram Oxalate Generic | 90 | 137 | 18 | $1,018 |
| Lacosamide Generic | 88 | 92 | Under 11 | $14K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 88 | 185 | 21 | $2,392 |
| Lamotrigine Generic | 72 | 76 | Under 11 | $876 |
| Entacapone Generic | 72 | 96 | 11 | $10K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 64 | 93 | 14 | $1,050 |
| Primidone Generic | 61 | 71 | Under 11 | $799 |
| Lorazepam Generic | 52 | 52 | 16 | $297 |
| Quetiapine Fumarate Generic | 49 | 52 | Under 11 | $748 |
| Carbamazepine Er Carbamazepine | 48 | 49 | Under 11 | $5,724 |
Brand drugs: - claims; generic drugs: 2,370 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vivek Jain $729 ($729 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $250.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 14 | $250 |
| Pfizer Inc. PFE | 12 | $191 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $76.3 |
| Eisai Inc. 4523.T | 3 | $62.74 |
| UCB, Inc. UCB.BR | 1 | $40.62 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $34.83 |
| ACADIA Pharmaceuticals Inc ACAD | 1 | $29.71 |
| Lilly USA, LLC LLY | 1 | $27.08 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $17.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.